Engage Worldwide to Drive Your Pancreatitis Therapy Trials

In pancreatitis, the pancreas effectively begins to digest itself. In some cases, the condition arises because of a blockage in the bile ducts, which prevents the digestive enzymes produced in the pancreas from reaching the small intestine where they are supposed to go to work. In other cases, the condition arises as a consequence of heavy drinking. In most cases, the obvious manifestation of pancreatitis is severe abdominal pain that even injected opioid analgesics cannot completely relieve.

Pancreatitis can cause serious complications and even death, so it’s important to identify and treat the condition quickly. If your research involves the development of tools and techniques for more rapid identification or treatment of pancreatitis, you’ll need to test the efficacy and safety of your work in clinical trials before bringing your therapy to market.

Worldwide Clinical Trials can provide the support you need to guide your drug through those clinical trials. With a global presence and more than 30 years of experience supporting research into immune-mediated inflammatory disorders (IMID), Worldwide is an internationally acclaimed expert in clinical trial management. We offer full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence studies that can help you understand the effects of your work over both the short and long term.

Researchers working with Worldwide know they will work with a stable team of project professionals who already have experience in IMID research. They’re ready to work with you from day one, whether you need insightful feedback on development plans, a detailed feasibility analysis, or all the resources and management skills required to bring your trials to conclusion on time and on budget.